The Food and Drug Administration on Thursday approved three new COVID-19 vaccines ahead of the 2024-2025 fall and winter infection season, as cases and hospitalizations for the illness continue to rise across the United States amid a summer surge.

This marks the third time since the original series that the vaccines have been updated to match more current strains in anticipation of the next season.

Recommended Stories

FDA panel recommends new COVID-19 vaccines, which could be available as early as September

Feds push booster as winter surge approaches

Pfizer and Moderna announce prices for new COVID-19 vaccine doses